Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: A cross-sectional study

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Momma, Haruki ^a   Niu, Kaijun ^b   Kobayashi, Yoritoshi ^c   Huang, Cong ^c   Chujo, Masahiko ^c   Otomo, Atsushi ^c   Tadaura, Hiroko ^d   Miyata, Toshio ^c   Nagatomi, Ryoichi ^a,c  

^a TOHOKU UNIVERSITY   (Japan)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MIYAGI UNIVERSITY   (Japan)

Author keywords

CRP; Endogenous secretory RAGE; Low grade inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; FEMALE; HUMAN; HUMAN TISSUE; JAPANESE; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84897980549     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-33     Document Type: Article

References (37)

1. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Yan SF, Ramasamy R, Schmidt AM, Circ Res 2010 106 842 853 10.1161/CIRCRESAHA.109.212217 20299674
2. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, J Biol Chem 1992 267 14987 14997 1321822
3. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, Goova MT, Moser B, Kislinger T, Lee DC, Kashyap Y, Stern DM, Schmidt AM, Circulation 2002 106 2827 2835 10.1161/01.CIR.0000039325.03698.36 12451010 (Pubitemid 35396983)
4. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM, Nat Med 1998 4 1025 1031 10.1038/2012 9734395 (Pubitemid 28417334)
5. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL, Nutr Metab Cardiovasc Dis 2009 19 129 134 10.1016/j.numecd.2008.03.004 18595673
6. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Yamagishi S, Adachi H, Nakamura K, Matsui T, Jinnouchi Y, Takenaka K, Takeuchi M, Enomoto M, Furuki K, Hino A, Shigeto Y, Imaizumi T, Metabolism 2006 55 1227 1231 10.1016/j.metabol.2006.05.007 16919543 (Pubitemid 44215942)
7. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y, Arterioscler Thromb Vasc Biol 2005 25 2587 2593 10.1161/01.ATV.0000190660.32863.cd 16224056 (Pubitemid 43732283)
8. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, Natali A, Ferrannini E, Gastaldelli A, J Clin Endocrinol Metab 2006 91 4628 4634 10.1210/jc.2005-2559 16926247 (Pubitemid 44833448)
9. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. Geroldi D, Falcone C, Emanuele E, D'Angelo A, Calcagnino M, Buzzi MP, Scioli GA, Fogari R, J Hypertens 2005 23 1725 1729 10.1097/01.hjh.0000177535.45785.64 16093918 (Pubitemid 41233433)
10. Total plasma Nepsilon-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects. Sebekova K, Krivosikova Z, Gajdos M, Clin Chem Lab Med 2013 52 139 149
11. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertu JA, Costa F, Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
12. Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men. Momma H, Niu K, Kobayashi Y, Guan L, Sato M, Guo H, Chujo M, Otomo A, Yufei C, Tadaura H, Saito T, Mori T, Miyata T, Nagatomi R, Osteoporos Int 2012 23 1673 1681 10.1007/s00198-011-1753-4 21901479
13. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention, Circulation 2003 107 499 511 10.1161/01.CIR.0000052939.59093.45 12551878 (Pubitemid 36158056)
14. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
15. Revised equations for estimated GFR from serum creatinine in Japan. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Am J Kidney Dis 2009 53 982 992 10.1053/j.ajkd.2008.12. 034 19339088
16. International physical activity questionnaire: 12-country reliability and validity. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P, Med Sci Sports Exerc 2003 35 1381 1395 10.1249/01.MSS.0000078924.61453.FB 12900694 (Pubitemid 36936159)
17. Exercise and Physical Activity Reference for Health Promotion 2006 (EPAR2006). Ishikawa-Takata K, Tabata I, J Epidemiol 2007 17 177 17827865
18. Comparison of relative validity of food group intakes estimated by comprehensive and brief-type self-administered diet history questionnaires against 16 d dietary records in Japanese adults. Kobayashi S, Murakami K, Sasaki S, Okubo H, Hirota N, Notsu A, Fukui M, Date C, Public Health Nutr 2011 14 1200 1211 10.1017/S1368980011000504 21477414
19. A study on a self-rating depression scale (author's transl). Fukuda K, Kobayashi S, Seishin Shinkeigaku Zasshi 1973 75 673 679 (in Japanese) 4798819
20. Prevalence of depression over a 12-month period in a nonpatient population. Barrett J, Hurst MW, DiScala C, Rose RM, Arch Gen Psychiatry 1978 35 741 744 10.1001/archpsyc.1978.01770300083009 306804 (Pubitemid 9064057)
21. Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Fukami A, Adachi H, Yamagishi S, Matsui T, Ueda S, Nakamura K, Enomoto M, Otsuka M, Kumagae S, Nanjo Y, Kumagai E, Esaki E, Murayama K, Hirai Y, Imaizumi T, Metabolism 2009 58 1688 1693 10.1016/j.metabol.2009.05.024 19616266
22. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Bierhaus A, Nawroth PP, Diabetologia 2009 52 2251 2263 10.1007/s00125-009-1458-9 19636529
23. Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status. Kankova K, Marova I, Zahejsky J, Muzik J, Stejskalova A, Znojil V, Vacha J, Metabolism 2001 50 1152 1160 10.1053/meta.2001.26757 11586486 (Pubitemid 33034698)
24. A meta-analysis of receptor for advanced glycation end products gene: four well-evaluated polymorphisms with diabetes mellitus. Niu W, Qi Y, Wu Z, Liu Y, Zhu D, Jin W, Mol Cell Endocrinol 2012 358 9 17 10.1016/j.mce.2012.02.010 22402134
25. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. Gaens KH, Ferreira I, van der Kallen CJ, van Greevenbroek MM, Blaak EE, Feskens EJ, Dekker JM, Nijpels G, Heine RJ, t Hart LM, de Groot PG, Stehouwer CD, Schalkwijk CG, J Clin Endocrinol Metab 2009 94 5174 5180 10.1210/jc.2009-1067 19890027
26. Association of RAGE gene polymorphisms with coronary artery disease in the Korean population. Yoon SJ, Park S, Shim CY, Park CM, Ko YG, Choi D, Park HY, Oh B, Kim H, Jang Y, Chung N, Coron Artery Dis 2007 18 1 8 10.1097/MCA.0b013e3280105b4d 17172923 (Pubitemid 44973749)
27. RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study. Sullivan CM, Futers TS, Barrett JH, Hudson BI, Freeman MS, Grant PJ, Diab Vasc Dis Res 2005 2 42 44 10.3132/dvdr.2005.005 16305072 (Pubitemid 40333204)
28. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial. Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, Charlton-Menys V, Bao W, Demicco DA, Preston GM, Deshmukh H, Tan K, Fuller JH, Diabetes 2011 60 2379 2385 10.2337/db11-0291 21771973
29. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD, Diabetes 2010 59 2027 2032 10.2337/db09-1509 20522598
30. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Thomas MC, Soderlund J, Lehto M, Makinen VP, Moran JL, Cooper ME, Forsblom C, Groop PH, Diabetologia 2011 54 2669 2677 10.1007/s00125-011-2186-5 21607631
31. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women. Semba RD, Ferrucci L, Sun K, Beck J, Dalal M, Varadhan R, Walston J, Guralnik JM, Fried LP, Aging Clin Exp Res 2009 21 182 190 10.1007/BF03325227 19448391
32. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME, FASEB J 2008 22 3716 3727 10.1096/fj.08-109033 18603587
33. sRAGE and risk of diabetes, cardiovascular disease and death. Selvin E, Halushka M, Rawlings A, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC, Diabetes 2013 62 2116 2121 10.2337/db12-1528 23396398
34. Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. Quade-Lyssy P, Kanarek AM, Baiersdorfer M, Postina R, Kojro E, J Lipid Res 2013 54 3052 3061 10.1194/jlr.M038968 23966666
35. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Santilli F, Bucciarelli L, Noto D, Cefalu AB, Davi V, Ferrante E, Pettinella C, Averna MR, Ciabattoni G, Davi G, Free Radic Biol Med 2007 43 1255 1262 10.1016/j.freeradbiomed.2007.06.017 17893038 (Pubitemid 47429934)
36. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. Aronson D, J Hypertens 2003 21 3 12 10.1097/00004872-200301000-00002 12544424 (Pubitemid 36143498)
37. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Wu L, Juurlink BH, Hypertension 2002 39 809 814 10.1161/hy0302.105207 11897769 (Pubitemid 34252881)